第7章 專利分析

第8章 現狀

第9章 企業簡介

圖表

REPORT HIGHLIGHTS

The global excipients market should reach nearly $6.9 billion by 2020 from approximately $6.3 billion in 2015, at a compound annual growth rate (CAGR) of 1.9% from 2015 to 2020.

This report provides:

An overview of the global market for excipients in pharmaceuticals, including examinations of the effects of a crisis in the global supply chain, the demands of quality by design (QbD), and concerns about drug safety.

Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.

Discussion of positive trends in the industry, including the development of creative ideas in response to the need for new excipients and new levels of cooperation between major players.

Coverage of the most important issues surrounding excipients: technological, regulatory, economic, and political.

SCOPE OF THE STUDY

This study encompasses excipients in pharmaceutical and biopharmaceutical markets. BCC analyzes each market by type and functional use, regulation, market projections, and market shares. The latest technological trends and developments are discussed. The last section provides company profiles of many of the companies relevant to the industry.

Organic is segmented into carbohydrates, oleochemicals, petrochemicals, proteins and others. Each is then further divided.

Inorganics are segmented into calcium salts, halites, metal oxides, silicates and others. Each is then further segmented.

ANALYSTS' CREDENTIALS

The study has been carried out by a team of professionals in the biotechnology industry. The project manager is Shalini S. Dewan who holds a master's degree in pharmaceutical chemistry and has over 14 years of industry experience. She was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. (Ranbaxy, Johnson & Johnson, Novartis and AstraZeneca).